the clinical validity of monitoring the tumor markers carcinoembryonic antigen ( cea ) and ca 19-9 were investigated in 602 patients with colorectal , gastric , and pancreatic carcinomas .
C0041365
tumor markers
C0007082
carcinoembryonic antigen